Trials / Completed
CompletedNCT01320774
Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 588 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this observational study is to evaluate the efficacy, tolerability, quality of life and handling of Daivobet® Gel by both physician and patient in daily practise.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Daivobet® Gel | Once daily on areas with plaque psoriasis, treatment duration up to 8 weeks for body skin areas except scalp (scalp up to 4 weeks), treatment may be repeated under medical surveillance. |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2011-03-22
- Last updated
- 2012-02-10
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01320774. Inclusion in this directory is not an endorsement.